These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 71463)

  • 1. Influence of HLA, ABO, and Rh(D) on survival after remission in acute myelogenous leukaemia.
    Harris R; Zuhrie SR; Taylor GM; Freeman CB; Wentzel J; Geary C; MacIver JE
    Lancet; 1977 Sep; 2(8039):653. PubMed ID: 71463
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transformation B (III) and A (II) blood groups into AB (IV) during transplantation of the bone marrow from HLA-identical sibs of A (II) and A (III) groups].
    Zotikov EA; Poreshina LP; Liubimova LS
    Biull Eksp Biol Med; 1998 Nov; 126(11):569-71. PubMed ID: 9883371
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution of the ABO and Rh D blood groups in patients with leukemia.
    Gurda M; Turowska B
    Pol Med Sci Hist Bull; 1970 Apr; 13(2):89-91. PubMed ID: 4990468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Distribution of the ABO and Rh-D systems in leukemic patients].
    Gurda M; Turowska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):303-8. PubMed ID: 4101120
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-B17 and the HLA-A1, B17 haplotype in acute myelogenous leukemia.
    Heise E; Parrish E; Cooper R
    Tissue Antigens; 1979 Aug; 14(2):98-104. PubMed ID: 291140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A and HLA-B antigens in acute leukemia: A2--B12 phenotypes correlate with longer survival in acute myelogenous leukemia.
    von Fliedner VE; Sultan Khan Z; Jeannet M
    Acta Haematol; 1981; 65(2):73-8. PubMed ID: 6785965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA linked resistance factors and survival in acute myelogenous leukemia.
    Oliver RT; Pillai A; Klouda PT; Lawler SD
    Cancer; 1977 Jun; 39(6):2337-41. PubMed ID: 266969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution of ABO and Rh factors in leukemia patients].
    Gurda M; Turowska B
    Przegl Lek; 1970; 26(7):606-7. PubMed ID: 4990216
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of group B in acute myeloid leukaemia.
    Undevia JV; Bhatia HM; Sharma RS; Parekh JG
    Indian J Med Res; 1966 Dec; 54(12):1145-9. PubMed ID: 5231698
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA, ABO and Rh antigens in blood donors with and without surface antigen for hepatitis B (HBsAg) (author's transl)].
    Dorlhiac P; Fuentes C; de la Fuente C; Velasco M
    Rev Med Chil; 1978 Oct; 106(10):755-7. PubMed ID: 105389
    [No Abstract]   [Full Text] [Related]  

  • 12. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
    Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
    Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell survival evaluated by RhD-negative cells transfused into RhD-positive patients.
    Onozaki F; Kishino K; Muroi K
    Transfus Apher Sci; 2015 Jun; 52(3):317-8. PubMed ID: 25634789
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genic and antigenic frequencies of ABO, Rhesus(D) systems and HLA in Ille et Vilaine].
    Genetet B; Fauchet R; Kerbaol M; Genetet N; Oger J; Bansard JY; Morel H
    C R Seances Soc Biol Fil; 1975; 169(2):395-9. PubMed ID: 126775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A, -B, -DRB1 allele and haplotype frequencies and comparison with blood group antigens in dialysis patients in the East Anatolia region of Turkey.
    Kayhan B; Kurtoglu EL; Taskapan H; Piskin T; Sahin I; Otlu G; Unal B
    Transplant Proc; 2013; 45(6):2123-8. PubMed ID: 23953521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary studies on antigenicity of chronic lymphatic leukemia cells in humans.
    Harlozińska A; Kotlarek-Haus S; Richter R; Brodzka W
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):403-15. PubMed ID: 4125923
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease.
    Meléndez M; Vargas-Tank L; Fuentes C; Armas-Merino R; Castillo D; Wolff C; Wegmann ME; Soto J
    Gut; 1979 Apr; 20(4):288-90. PubMed ID: 109357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA types and ABO blood groups in patients with infectious mononucleosis.
    Rosdahl N; Svejgaard A
    Tissue Antigens; 1979 Mar; 13(3):223-7. PubMed ID: 108811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-A9 and survival in acute lymphocytic leukemia and myelocytic leukemia.
    Cohen E; Singal DP; Khurana U; Gregory SG; Cox C; Sinks L; Henderson E; Fitzpatrick JE; Higby D
    Prog Clin Biol Res; 1977; 16():65-70. PubMed ID: 269457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.